EdgarLookup

ORAMED PHARMACEUTICALS INC. — 8-K Filings

261 8-K filings on record

This page lists all 8-K filings submitted to the SEC by ORAMED PHARMACEUTICALS INC. (ORMP), sorted by most recent first. Each row links to the full filing on EdgarLookup. ORAMED PHARMACEUTICALS INC. has filed 261 8-K documents with the SEC since 2002. To view all SEC filings by ORAMED PHARMACEUTICALS INC., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 10-QT 10KSB 10KSB/A 10QSB 10QSB/A 3 3/A 4 4/A 424B3 424B5 424B7 5 8-A12B 8-A12G 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D D/A DEF 14A EFFECT FWP NT 10-K NT 10-Q NTN 10Q POS AM PRE 14A PRER14A REGDEX RW S-1 S-1/A S-3 S-3MEF S-8 SB-2 SB-2/A SC 13D SC 13D/A SC 13G SC 13G/A SC 14F1 SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-22-055429 Sep 13, 2022
8-K CURRENT REPORT 0001213900-22-054868 Sep 8, 2022 Sep 1, 2022
8-K CURRENT REPORT 0001213900-22-037750 Jul 7, 2022
8-K 0001213900-22-036294 Jun 30, 2022
8-K CURRENT REPORT 0001213900-22-017667 Apr 4, 2022 Mar 30, 2022
8-K CURRENT REPORT 0001213900-22-009794 Feb 28, 2022
8-K CURRENT REPORT 0001213900-22-001660 Jan 12, 2022
8-K CURRENT REPORT 0001213900-21-064085 Dec 8, 2021 Dec 7, 2021
8-K CURRENT REPORT 0001213900-21-063984 Dec 7, 2021
8-K CURRENT REPORT 0001213900-21-056803 Nov 4, 2021 Nov 3, 2021
8-K CURRENT REPORT 0001213900-21-055258 Oct 29, 2021
8-K CURRENT REPORT 0001213900-21-046043 Sep 1, 2021 Aug 26, 2021
8-K CURRENT REPORT 0001213900-21-045898 Aug 31, 2021 Aug 30, 2021
8-K CURRENT REPORT 0001213900-21-040394 Aug 5, 2021
8-K CURRENT REPORT 0001213900-21-039829 Aug 2, 2021 Jul 25, 2021
8-K CURRENT REPORT 0001213900-21-037056 Jul 15, 2021 Jul 14, 2021
8-K CURRENT REPORT 0001213900-21-032720 Jun 16, 2021
8-K CURRENT REPORT 0001213900-21-029048 May 25, 2021 May 23, 2021
8-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-21-025365 May 10, 2021 May 6, 2021
8-K CURRENT REPORT 0001213900-21-017117 Mar 23, 2021
8-K CURRENT REPORT 0001213900-21-016531 Mar 19, 2021 Mar 18, 2021
8-K CURRENT REPORT 0001213900-21-006805 Feb 4, 2021
8-K CURRENT REPORT 0001213900-20-040364 Dec 2, 2020
8-K CURRENT REPORT 0001213900-20-040263 Dec 1, 2020
8-K CURRENT REPORT 0001213900-20-032805 Oct 22, 2020
8-K CURRENT REPORT 0001213900-20-027361 Sep 18, 2020 Sep 16, 2020
8-K CURRENT REPORT 0001213900-20-025857 Sep 9, 2020 Sep 2, 2020
8-K CURRENT REPORT 0001213900-20-024016 Aug 27, 2020 Aug 21, 2020
8-K FORM 8-K 0001213900-20-020031 Aug 4, 2020 Aug 3, 2020
8-K CURRENT REPORT 0001213900-20-017505 Jul 15, 2020
8-K CURRENT REPORT 0001213900-20-008913 Apr 9, 2020
8-K CURRENT REPORT 0001213900-20-005018 Feb 28, 2020 Feb 27, 2020
8-K CURRENT REPORT 0001213900-20-004778 Feb 26, 2020
8-K CURRENT REPORT 0001213900-19-025444 Dec 6, 2019 Dec 5, 2019
8-K CURRENT REPORT 0001213900-19-022717 Nov 12, 2019
8-K CURRENT REPORT 0001213900-19-017287 Sep 5, 2019 Aug 29, 2019
8-K FORM 8-K 0001213900-19-016472 Aug 21, 2019 Aug 18, 2019
8-K CURRENT REPORT 0001213900-19-013773 Jul 29, 2019 Jul 23, 2019
8-K FORM 8-K 0001213900-19-011856 Jul 1, 2019 Jun 25, 2019
8-K CURRENT REPORT 0001213900-19-009033 May 16, 2019 May 13, 2019
8-K CURRENT REPORT 0001213900-19-006512 Apr 16, 2019 Apr 12, 2019
8-K CURRENT REPORT 0001213900-19-005120 Mar 28, 2019 Mar 25, 2019
8-K CURRENT REPORT 0001213900-19-004051 Mar 13, 2019 Mar 11, 2019
8-K CURRENT REPORT 0001213900-18-017333 Dec 14, 2018 Dec 11, 2018
8-K CURRENT REPORT 0001213900-18-015178 Nov 8, 2018 Nov 4, 2018
8-K CURRENT REPORT 0001213900-18-012630 Sep 17, 2018
8-K CURRENT REPORT 0001213900-18-011939 Aug 30, 2018 Aug 28, 2018
8-K CURRENT REPORT 0001213900-18-008780 Jul 5, 2018 Jul 2, 2018
8-K CURRENT REPORT 0001213900-18-002084 Feb 20, 2018 Feb 14, 2018
8-K CURRENT REPORT 0001213900-17-009429 Sep 5, 2017 Aug 30, 2017